Archives
-
HRP Goat Anti-Mouse IgG (H+L): Uses
2026-09-15
The Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated reagent K1221 is a polyclonal Horseradish Peroxidase conjugated secondary antibody for detecting mouse IgG in Western blotting, ELISA, IHC, and ICC. Its formulation and storage conditions support reproducible immunodetection when the primary antibody, substrate, and assay controls are appropriately matched.
-
TBST Workflows for uPAR·uPA Assays
2026-09-15
TBST provides a practical, low-background foundation for Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. This workflow-focused guide connects disciplined buffer handling with the conformation-aware uPAR·uPA inhibitor study while clearly separating assay quality from therapeutic efficacy.
-
Gamithromycin PK/PD in a Murine Lung Infection Model
2026-09-14
Yang et al. established an in vivo pharmacokinetic/pharmacodynamic framework for Gamithromycin against Pasteurella multocida in a neutropenic mouse lung infection model. The strong relationship between the unbound 24-hour exposure-to-MIC ratio and antibacterial effect provides quantitative benchmarks for dose optimization while highlighting the limits of transferring murine results directly to cattle.
-
FCCP for Mitochondrial Biology Research
2026-09-14
FCCP converts mitochondrial proton-gradient collapse into a measurable stress test for respiration, ATP dependence, and HIF-linked signaling. This guide pairs practical FCCP workflows with a careful extension to MARCH5-controlled mitochondria-to-peroxisome trafficking, while separating established evidence from assay-planning recommendations.
-
Recombinant Mouse IFN-γ for MASH-HCC Assays
2026-09-13
Recombinant Mouse IFN-γ provides a defined immune stimulus for separating tumor-intrinsic antigen-presentation defects from failures in macrophage or T-cell function. This practical guide translates bile acid–MASH-HCC findings into dose, timing, co-culture, antiviral, and troubleshooting workflows.
-
P. vivax B-Cell Epitopes for Precision Surveillance
2026-09-12
A 2026 study combined computational antigen prioritization, peptide serology, multiplex validation, and conservation analysis to identify immunodominant Plasmodium vivax B-cell epitopes. Four candidates showed strong species-discriminating performance, while one MSP9 epitope provided moderate discrimination of asymptomatic infection, supporting more targeted malaria surveillance.
-
L1023 Anti-Cancer Compound Library for Oncology
2026-09-11
The L1023 Anti-Cancer Compound Library combines 1164 pre-dissolved bioactive compounds for cancer research and high-throughput screening. Its target diversity includes a BRAF kinase inhibitor class, mTOR-directed agents, proteasome inhibitors, deubiquitinase inhibitors, and HDAC inhibitors, while the cited STING study supplies a mechanistic framework for immune-oncology screening.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-11
HRP Goat Anti-Mouse IgG (H+L) Antibody is an affinity-purified, HRP-conjugated secondary reagent for detecting mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be used as a universal secondary for non-mouse or non-IgG primaries, and assay-specific dilution and incubation conditions require laboratory validation.
-
Bile Acid Retention Drives Immune Escape in MASH-HCC
2026-09-10
A 2026 Cancer Letters study identifies a GPR120–FXR/ABCB11–bile acid–NLRC5 pathway that suppresses MHC-I antigen presentation in MASH-associated hepatocellular carcinoma. Its genetic and pharmacological experiments show that reducing intracellular bile acid retention can restore tumor antigenicity and improve anti-PD-1 responses in mice.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-09-10
This study identifies Kupffer-cell TMEM16F, rather than TMEM16F in T or B cells, as a key determinant of liver protection during Listeria monocytogenes infection. Its findings connect plasma-membrane repair and lipid scrambling with control of hepatic inflammation, tissue injury, and metabolic disruption, providing a cell-specific framework for studying infection-associated inflammatory cell death.
-
Aclacinomycin A: From DNA Damage to rDNA Stress
2026-09-09
Aclacinomycin A research extends beyond general cytotoxicity to reveal how topological stress, persistent DNA lesions, and nucleolar compartmentalization can shape assay interpretation. This article connects aclarubicin pharmacology with rDNA damage biology while defining practical controls for apoptosis and DNA damage studies.
-
Tp47 Drives Macrophage Inflammatory Senescence
2026-09-09
The reference study identifies a mechanistic link between the Treponema pallidum protein Tp47, PKM2-dependent metabolic reprogramming, and inflammatory senescence in macrophages. Its findings suggest that pathogen-driven glycolysis, lactate production, EIF2AK2 signaling, and NLRP3-associated pyroptosis should be evaluated together when interpreting senescent cell detection in infection models.
-
Imatinib Hydrochloride: Mechanism and Research Use
2026-09-08
Imatinib hydrochloride, also called STI571 hydrochloride, is an ATP-site tyrosine kinase inhibitor for cancer research that targets v-Abl, c-Kit, and PDGFR. Its reported biochemical potency and research applications support chronic myelogenous leukemia and gastrointestinal stromal tumor models, while assay-specific cellular potency must be interpreted separately.
-
HyperFluor 488: A Decision Framework
2026-09-08
HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody supports sensitive fluorescent detection of human IgG across translational immunoassays. This article explains when it is scientifically appropriate for vaccine research, how to avoid species-mismatch errors, and how to connect binding-antibody data with preclinical findings.
-
Western Secondary Antibody Dilution Buffer Guide
2026-09-07
This scenario-driven guide explains how Western Secondary Antibody Dilution Buffer, SKU K4115, can improve the consistency of protein-detection Western blots used alongside cell viability, proliferation, and cytotoxicity assays. It covers compatibility, reuse, optimization, data interpretation, and practical product-selection criteria.